These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 10580402)

  • 1. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
    Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection.
    Dyer WB; Geczy AF; Kent SJ; McIntyre LB; Blasdall SA; Learmont JC; Sullivan JS
    AIDS; 1997 Nov; 11(13):1565-74. PubMed ID: 9365760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
    Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
    J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
    Bofill M; Mocroft A; Lipman M; Medina E; Borthwick NJ; Sabin CA; Timms A; Winter M; Baptista L; Johnson MA; Lee CA; Phillips AN; Janossy G
    AIDS; 1996 Jul; 10(8):827-34. PubMed ID: 8828739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients].
    Zhang HW; Qiu ZF; Li TS
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1973-6. PubMed ID: 15730808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).
    Birch MR; Learmont JC; Dyer WB; Deacon NJ; Zaunders JJ; Saksena N; Cunningham AL; Mills J; Sullivan JS
    J Clin Virol; 2001 Oct; 22(3):263-70. PubMed ID: 11564591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
    J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection.
    Lieberman J; Trimble LA; Friedman RS; Lisziewicz J; Lori F; Shankar P; Jessen H
    AIDS; 1999 May; 13(8):891-9. PubMed ID: 10371169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years.
    Arnó A; Ruiz L; Juan M; Zayat MK; Puig T; Balagué M; Romeu J; Pujol R; O'Brien WA; Clotet B
    AIDS; 1998 May; 12(7):697-704. PubMed ID: 9619800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of naïve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population.
    Roman M; Rodriguez JW; Pagán NO; Rios-Olivares E; Amill A; Hunter R
    P R Health Sci J; 2002 Sep; 21(3):195-201. PubMed ID: 12243109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
    Choremi-Papadopoulou H; Tsalimalma K; Dafni U; Dimitracopoulou A; Kordossis T
    J Med Virol; 2004 Jun; 73(2):235-43. PubMed ID: 15122798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations.
    Nokta M; Rossero R; Nichols J; Rosenbaum M; Pollard RB
    AIDS Res Hum Retroviruses; 1999 Feb; 15(3):255-64. PubMed ID: 10052756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T-cell subsets variation during clinical and immunological progression in vertically HIV-infected children].
    Resino García S; Bellón Cano JM; Navarro Caspistegui J; Gurbindo Gutiérrez D; León Leal JA; Muñoz-Fernández MA
    Medicina (B Aires); 2001; 61(5 Pt 1):557-65. PubMed ID: 11721322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
    Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
    AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.